- Dispersion improvement
- Active protection
- Particle-size target
- Loading and encapsulation
- Release evaluation
- Formula compatibility
NANO LIPOSOME DELIVERY
Turn difficult actives into measurable delivery systems.
Connect carrier selection, particle control, active loading and formula validation.
PROJECT FIT
Start by confirming whether this is the right route.
The technology is selected against the material, target specification, formula conditions and evidence needed.
- Poorly water-compatible botanical actives
- Oil-soluble vitamins
- Selected biochemical actives
- Plant oils and lipophilic compounds
CHALLENGE → TECHNICAL RESPONSE
Connect each project problem with a review action.
These are development routes, not universal performance claims. The applicable route is confirmed after reviewing the actual material and formula.
Low water compatibility
Many botanical actives, vitamins and oils are difficult to disperse in water-based systems.
Define the active and carrier
Review active properties, target loading, lecithin carrier and intended formula format.
Active instability
Light, oxygen, heat and the surrounding formula can reduce active stability.
Build and characterize
Optimize preparation conditions and measure particle size, distribution and active loading.
Unverified delivery claims
Small particle size alone does not prove skin penetration or finished-product efficacy.
Validate in the formula
Review storage stability, compatibility, release behavior and the evidence needed for claims.
DEVELOPMENT WORKFLOW
From requirement to reviewed sample.
- 01Active review
- 02Carrier selection
- 03Process screening
- 04Particle characterization
- 05Stability evaluation
- 06Formula validation
METHODS & SUPPORTING DATA
Verification follows the technical question.
Particle size & distribution
DLS or another suitable method under defined sample conditions.
Active loading
Product-suitable assay for total, free or encapsulated active where the method allows.
Physical stability
Appearance, aggregation, precipitation and particle change under defined storage conditions.
Formula compatibility
Observation in the intended pH, process, packaging and dosage form.
EVIDENCE & TECHNICAL BOUNDARIES
Know what the data supports—and what still needs validation.
Internal tests, third-party reports, typical data and customer-formula results must be identified separately.
Particle size
A target such as below 50 nm must be specified and verified for the actual sample; it is not a default platform claim.
Skin delivery
Penetration depth and delivery performance require an appropriate test model and finished-formula context.
Safety
Carrier selection and ingredient safety do not replace finished-product safety assessment.
Stability
Liposome and finished-product stability depend on composition, process and packaging.
Efficacy
Antioxidant, brightening, wrinkle or nourishment claims require relevant substantiation.
Typical or historical data do not replace the applicable batch COA. Finished-formula stability, compatibility, safety and claim substantiation remain the customer's responsibility unless separately agreed in writing.
PROJECT SUPPORT
Submit a technical request.
Share the ingredient, formula format, target pH, process, market and evidence needed.